![Jason Chin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Chin active positions
Companies | Position | Start | End |
---|---|---|---|
GENUS PLC | Director/Board Member | 31/03/2021 | - |
Independent Dir/Board Member | 31/03/2021 | - | |
Constructive Bio Ltd.
![]() Constructive Bio Ltd. BiotechnologyHealth Technology Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Founder | - | - |
Career history of Jason Chin
Statistics
International
United Kingdom | 3 |
Operational
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Process Industries | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GENUS PLC | Process Industries |
Private companies | 1 |
---|---|
Constructive Bio Ltd.
![]() Constructive Bio Ltd. BiotechnologyHealth Technology Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself. | Health Technology |
- Stock Market
- Insiders
- Jason Chin
- Experience